Search details
1.
Everolimus in Neuroendocrine Tumors of the Gastrointestinal Tract and Unknown Primary.
Neuroendocrinology
; 106(3): 211-220, 2018.
Article
in English
| MEDLINE | ID: mdl-28554173
2.
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial.
Lancet
; 381(9869): 817-24, 2013 Mar 09.
Article
in English
| MEDLINE | ID: mdl-23312829
3.
Everolimus for advanced pancreatic neuroendocrine tumors.
N Engl J Med
; 364(6): 514-23, 2011 Feb 10.
Article
in English
| MEDLINE | ID: mdl-21306238
4.
A phase 2 study of everolimus combined with trastuzumab and paclitaxel in patients with HER2-overexpressing advanced breast cancer that progressed during prior trastuzumab and taxane therapy.
Breast Cancer Res Treat
; 141(3): 437-46, 2013 Oct.
Article
in English
| MEDLINE | ID: mdl-24101324
5.
Reply to V. Amoroso et al.
J Clin Oncol
; 35(13): 1488-1489, 2017 05 01.
Article
in English
| MEDLINE | ID: mdl-28113028
Results
1 -
5
de 5
1
Next >
>>